Oragenics, Inc. OGEN
0.49
(0.01)
(2.00%)
as of 25 Sep
- Market cap
- $2.3M
- P/E
- 0.4×
Follow OGEN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (1,307.07%) | (311.00%) | (243.94%) | (192.73%) |
+8 more TTM periods Free account |
|
| (264.23%) | (173.03%) | (170.58%) | (121.77%) | ||
ROIC |
0.00% | (8,025.60%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(274.71%) | (158.96%) | (118.85%) | (110.92%) | |
Average Days of Receivables |
— | — | 0.00 | — | |
Free Cash Flow per Share |
(2.30) | (2.17) | (4.29) | (5.40) | |
Free Cash Flow |
(10.21) | (9.33) | (9.25) | (8.43) | |
| Other line items | |||||
Cash ROIC |
(135.47%) | (75.96%) | (55.43%) | (39.70%) | |
Accounts Receivable Turnover |
— | — | 0.00 | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.01 | 0.95 | 0.94 | 0.77 | |
Depreciation/Fixed assets |
— | — | 0.00 | 0.00 | |
Capex/Depreciation |
— | — | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.30) | (2.17) | (4.29) | (5.40) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates